Active ingredient
The component intended to produce a biological effect. Matching an ingredient name does not establish that two complete products have the same quality or regulatory status. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Adverse event
An unwanted medical occurrence after exposure to a product, whether or not the product is known to have caused it. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Agonist
A substance that binds to a biological target and activates or increases a signaling response.
Antagonist
A substance that binds to a biological target and reduces or blocks a signaling response.
Bioavailability
The extent and rate at which a substance reaches systemic circulation; it is a pharmacokinetic concept, not evidence of clinical benefit.
Biomarker
A measurable biological characteristic, such as a laboratory value. A biomarker change does not automatically demonstrate a meaningful health outcome. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Blinding
A study design feature that keeps participants, clinicians, assessors, or analysts from knowing assigned interventions when feasible, helping reduce expectation and assessment bias. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Compounded drug
A preparation made by a licensed compounder under applicable law for a patient need. Compounded drugs are not FDA approved. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Confidence interval
A range that conveys uncertainty around an estimate. Wider intervals generally reflect less precision.
Confounding
When another factor is related to both an exposure and an outcome, making it difficult to isolate the exposure's effect. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Contraindication
A situation in which a medicine or procedure should not be used because the risk is considered unacceptable. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Control group
The comparison group in a study. A useful control helps distinguish an intervention's effects from expectation, natural change, or other influences. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Endpoint
A predefined outcome a study measures to answer its research question.
External validity
How well study findings may apply beyond the participants, setting, product, and conditions actually studied. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
FDA-approved drug
A specific complete drug product reviewed and approved by the FDA for defined uses. Approval does not transfer to compounded or otherwise unapproved versions. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Half-life
The time required for a concentration to decline by half under defined conditions; it does not determine whether a product is appropriate for someone.
HPLC
High-performance liquid chromatography, an analytical method that can help separate and characterize components in a sample.
Identity testing
Analytical work intended to determine whether a sample matches a claimed chemical identity. It does not establish clinical outcomes.
Impurity
An unintended component in a material. Its relevance depends on identity, amount, context, and validated analytical testing.
Indication
A disease, condition, or defined use for which a medical product is authorized or studied. Evidence for one indication may not apply to another. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Informed consent
A process for understanding a proposed intervention, alternatives, expected benefits, material risks, and uncertainties before choosing. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Investigational product
A drug or other intervention being studied in research. Investigational status is not the same as FDA approval or evidence of benefit for routine use. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Lyophilization
A freeze-drying process used to remove water from a material. It is a manufacturing concept, not a clinical-evidence claim.
Mass spectrometry
An analytical technique that measures ions and can help characterize molecular mass and composition.
Meta-analysis
A statistical synthesis of results from multiple studies. Its value depends on the quality and comparability of the included evidence.
Peer review
Evaluation of a manuscript by other subject-matter experts before publication. It can improve scrutiny but cannot ensure that every conclusion is correct. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Peptide
A chain of amino acids. The category includes natural signaling molecules, approved medicines, and experimental compounds with very different evidence and safety profiles. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Pharmacodynamics
The study of biological effects of a substance and the relationship between exposure and response.
Pharmacokinetics
The study of how a substance is absorbed, distributed, metabolized, and eliminated.
Pharmacovigilance
The detection, assessment, understanding, and prevention of adverse effects or other medicine-related problems. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Placebo
An inactive or comparison intervention used to help separate a treatment effect from expectation, natural change, and study procedures. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Placebo-controlled
A study design that compares an intervention with a placebo or inactive comparison, when appropriate, to help estimate effects beyond expectation and study procedures. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Preclinical
Research conducted before or apart from clinical testing in people, such as cell, animal, or computational studies.
Preclinical research
Laboratory or animal research conducted before or alongside human research. It can inform hypotheses but cannot establish human safety or benefit on its own. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Preregistration
Recording a study's planned methods and outcomes before results are known. Comparing the plan with the final report can help readers assess selective reporting. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Randomization
A process that assigns participants by chance to study groups to help balance known and unknown differences.
Randomized controlled trial
A study that assigns participants by chance to comparison groups, helping reduce important forms of bias. Study quality still depends on design and execution. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Receptor
A cellular molecule that recognizes a signal and can initiate or modify a biological response.
Replication
A separate study that tests whether a finding can be reproduced, ideally by independent investigators and in an appropriate population. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Study protocol
The written plan for a research study, including who can participate, what happens, what outcomes are measured, and how results are analyzed. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Surrogate endpoint
A laboratory measure or intermediate outcome used in place of a direct patient outcome. A change may not reliably predict how someone feels, functions, or survives. Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Systematic review
A structured review that uses a planned method to identify, assess, and synthesize relevant evidence.
Translational research
Work that aims to move discoveries between basic science, clinical research, and real-world health practice.
